16817690

Source:http://linkedlifedata.com/resource/pubmed/id/16817690

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017387, umls-concept:C0036636, umls-concept:C0123759, umls-concept:C0205263, umls-concept:C0205470, umls-concept:C0302350, umls-concept:C0871261, umls-concept:C1517564, umls-concept:C1533685, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	6
pubmed:dateCreated	2006-7-4
pubmed:abstractText	The authors investigated immunogene therapy for malignant glioma to determine whether its therapeutic efficacy could be improved.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100896471
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:issn	1092-0684
pubmed:author	pubmed-author:BlaeseMM, pubmed-author:RamseyJJ, pubmed-author:TanakaRR, pubmed-author:XanthopoulosK GKG, pubmed-author:YamanakaRR, pubmed-author:ZulloS ASA
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	e7
pubmed:meshHeading	pubmed-meshheading:16817690-Animals, pubmed-meshheading:16817690-Apoptosis, pubmed-meshheading:16817690-Brain Neoplasms, pubmed-meshheading:16817690-CD8-Positive T-Lymphocytes, pubmed-meshheading:16817690-Cell Line, Tumor, pubmed-meshheading:16817690-Cricetinae, pubmed-meshheading:16817690-Dendritic Cells, pubmed-meshheading:16817690-Gene Therapy, pubmed-meshheading:16817690-Genetic Engineering, pubmed-meshheading:16817690-Glioma, pubmed-meshheading:16817690-Immunotherapy, pubmed-meshheading:16817690-Interleukin-12, pubmed-meshheading:16817690-Kidney, pubmed-meshheading:16817690-Mice, pubmed-meshheading:16817690-Mice, Inbred C57BL, pubmed-meshheading:16817690-Recombinant Proteins, pubmed-meshheading:16817690-Semliki forest virus, pubmed-meshheading:16817690-Survival Rate, pubmed-meshheading:16817690-Transfection
pubmed:year	2000
pubmed:articleTitle	Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.
pubmed:affiliation	Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. ryaman@pop11.odn.ne.jp
pubmed:publicationType	Journal Article